2015 PDA/FDA Joint Regulatory Conference
Pharmaceutical Technology spoke with Monica Caphart, FDA, and Susan Schniepp, PDA, about the 2015 PDA/FDA Joint Regulatory Conference taking place in Washington, DC, in September.
Monica Caphart, leveraging and collaboration program manager with the Division of Human Resource Development at FDA, and Susan Schniepp, chair of PDA Regulatory Affairs and Quality Advisory Board, spoke with BioPharm International about the theme of the 2015 PDA/FDA Joint Regulatory Conference, how legislative tools have improved the quality of drug products, and what attendees can expect from conference sessions and regulatory authority interactions.
The 2015 PDA/FDA Joint Regulatory Conference will take place in Washington, DC, September 28–30, 2015.
Novo Nordisk Hemophilia Treatment Gets Positive Opinion from CHMP
October 23rd 2024As many as 30% of people living with severe hemophilia A develop inhibitors such as TFPI, which can be produced by the body’s immune response to clotting factors in replacement therapy, often limiting the effectiveness of that therapy.
